LMND Company Profile and Key Details

Lemonade, Inc. trades at a P/E ratio of -26.67, slightly below the S&P 500 average, with a price-to-sales ratio of 6.36 and a price-to-book ratio of 8.27 trading at moderately above to book value. The P/FCF stands at -181.29, also below market averages.

Lemonade, Inc. has 73.89 million shares outstanding. The public float is 62.19 million shares, elevated short interest at 31.72% of float. This equals 17.70 million shares. The short ratio is 8.56 days. Institutional investors hold 65.76% of the float. Insiders own 18.41%. SoftBank Group Capital Ltd holds 7.11 million shares, Wininger Shai has 3.38 million shares and Schreiber Daniel A. has 1.51 million shares. Over the past six months, insider transactions show net selling. They sold 310.30 thousand shares across 23 transactions.

Lemonade, Inc. (NYSE:LMND) closed at $61.47 USD, gaining $0.40 (0.65%) from the previous close of $61.07. The stock is currently mid-range between its 52-week high and low $24.31 and $99.90. With a market capitalization of about $4.70 billion, Lemonade, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~2.22). Key stats such as the average daily volume over the past year has been around 2.56 million shares, volume is running light vs its 52-week average. Headquartered in New York City, NY, Lemonade, Inc. operates in the Financial Services sector and the Insurance - Property & Casualty industry. Led by CEO Daniel Asher Schreiber, the company employs approximately 1,235 people and listed since July 02, 2020. Lemonade, Inc. provides various insurance products in the United States and Europe.

Lemonade, Inc. generated EPS of -$2.38 over the past year. Five-year average earnings growth is -8.22%. The latest quarter delivered EPS of -$0.51. The next quarter is forecast at -$0.58. Next year's EPS is expected at $10.71. Analyst sentiment is bearish. Analyst rating data shows there are 3 Strong Buy ratings, 1 Buy ratings, 3 Hold ratings, 0 Sell rating and 10 Strong Sell ratings. Price targets range from $98.00 to $23.00. The high target offers 59.43% upside. The low target suggests -62.58% downside. The mean target is $52.76. This offers -14.17% upside. Lemonade, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended November 05, 2025, missed forecasts by -29.8%. The prior quarter beat by -25.93%. Over the last six quarters, Apple has recorded several small beats. These include -4.71% in July 30, 2024.

Lemonade, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $75.15. This means the shares are trading below this model’s fair value.

Short-term trend indicators are mixed aligned (SMA20 -18.62%, SMA50 -27.27%, SMA200 -4.43%). The stock’s 14-day RSI is 35.17 (weak momentum), while the ATR of 5.78 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -44.77% below its high and over 126.94% above its low. Average 10-day trading volume of 1.56 million shares is below the 3-month average of 2.55 million, indicating normal recent market interest.

Our AI price prediction model suggests that Lemonade, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -2.54%, with price expected at $59.91 by April 16, 2026, within a range of $52.40 to $66.91 3-Month Outlook: Projected rise of 32.72%, reaching $81.58 by July 01, 2026, with a range of $80.18 to $83.13. 1-Year Outlook: Projected gain of 36.46%, with price at $83.88 by April 02, 2027, within a range of $79.72 to $87.64.

Lemonade, Inc. (NYSE:LMND) shares are flat 9.92% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Lemonade, Inc. trading at a premium to the broader market with a P/E of -26.67. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $37.99, suggesting -38.2% downside. Our AI forecast model points to short-term weakness (-2.54% over two weeks), a medium-term rise (32.72% over three months), and a longer-term gain (36.46% over one year), with expected trading ranges indicating moderate volatility.